1. Palantir Technologies (NYSE: PLTR)
Palantir Technologies surged by 6.58%. Palantir Technologies' co-founder Peter Thiel sold nearly $600 million in shares, totaling over $1 billion this year. Internal trades revealed on October 7th and October 1st. Wedbush raised Palantir's price target to $45. Raymond James downgraded the rating to Market Perform.
2. Carvana (NYSE: CVNA)
Carvana surged by 6.25%. Carvana disclosed insider transactions multiple times, with significant sales by major shareholder Garcia Ernest C. II. Analysts Wedbush and Citigroup maintained neutral ratings on Carvana, adjusting price targets to $175 and $195, respectively.
3. Edwards Lifesciences (NYSE: EW)
Edwards Lifesciences surged by 6.21%. Edwards Lifesciences' recent activity includes RBC Capital maintaining an "Outperform" rating with a $75 price target, Canaccord Genuity holding with a $66 target, and Citigroup supporting a "Buy" at $77. Jefferies downgraded to "Hold" with a $70 target.
4. Palo Alto Networks (Nasdaq: PANW)
Palo Alto Networks gained solidly by 5.09%. Palo Alto Networks completed the acquisition of IBM QRadar SaaS assets. Exane BNP Paribas initiated coverage with an Outperform rating and a $410 target. Goldman Sachs maintained a Buy rating, adjusting the target to $425. Recent insider transactions disclosed.
5. Synopsys (Nasdaq: SNPS)
Synopsys gained solidly by 4.63%. Synopsys accelerates AI innovation through system design, launching UCIe IP solutions. The company hosted a successful Developers Conference in Shanghai, focusing on the future of universal intelligence and fostering advancements from chip design to broader technological innovations. Senior executives highlighted market growth opportunities.
Comments
No comments yet